Patient Demographics, TNM Classification, Tumor Characteristics, TBR on Preoperative PET/CT Scan, and Information Regarding CLI Imaging
| Patient no. | Age (y) | Preoperative TNM | Postoperative TNM | PSA (µg/L) | Gleason score, preoperative biopsy | TBR on PSMA PET | Intraoperative injected activity (MBq) | Time between injection and CLI imaging (h:min) | Estimated* activity in prostate at start of CLI imaging (kBq) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 67 | cT3bN0M0 | pT3aN0R1 | 29.9 | 4 + 4 = 8 | 4.9 | 118.0 | 01:35 | 111 |
| 2 | 71 | cT2bN0M0 | pT3aN0R1 | 4.4 | 4 + 4 = 8 | 8.1 | 68.4 | 01:04 | 93 |
| 3 | 58 | cT1cN0M0 | pT2cN0R0 | 5.3 | 4 + 4 = 8 | 1.8 | 88.1 | 01:25 | 26 |
| 4 | 73 | cT3bN1M0 | pT3bN1R0 | 8.3 | 4 + 5 = 9 | 8.9 | 75.6 | 00:59 | 92 |
| 5 | 66 | cT3bN0M0 | pT3bN0R0 | 2.7 | 4 + 4 = 8 | 2.1 | 96.7 | 01:00 | 52 |
| 6 | 63 | cT2aN0M0 | pT2N0R0 | 6.4 | 4 + 5 = 9 | 3.8 | 64.6 | 01:02 | 37 |
| 7 | 55 | cT2cN0M0 | pT3aN1R0 | 9.3 | 4 + 4 = 8 | 3.7 | 62.1 | 01:14 | 61 |
| 8 | 48 | cT3bN1M0 | pT3bN1R1 | 4.4 | 4 + 5 = 9 | 4.4 | 23.4 | 01:05 | 48 |
| 9 | 73 | cT2cN0M0 | PT3aN0R0 | 5.6 | 4 + 3 = 7 | 2.7 | 44.7 | 00:44 | 26 |
| 10 | 69 | cT3aN0M0 | pT3aN0R1 | 65 | 4 + 5 = 9 | 2.4 | 47.9 | 00:56 | 151 |
| 11 | 72 | cT2bN0M0 | pT3bN1R0 | 8.7 | 4 + 4 = 8 | 2.8 | 47.6 | 01:05 | 42 |
| 12 | 76 | cT1cN0M0 | pT2N0R1 | 9.2 | 3 + 4 = 7 | 2.5 | 65.4 | 01:02 | 69 |
| 13 | 65 | cT2cN0M0 | pT3aN0R1 | 5.1 | 4 + 3 = 7 | 1.7 | 121.1 | 01:26 | 8 |
| 14 | 67 | cT2bN0M0 | pT3bN0R1 | 18.6 | 4 + 5 = 9 | 3.7 | 37.4 | 01:14 | 14 |
| 15 | 74 | cT1cN0M0 | pT2cN0R0 | 7.9 | 4 + 4 = 8 | 3.5 | 70.2 | 01:45 | 33 |
↵* Based on uptake on preoperative PET imaging (uptake in prostate as percentage injected activity).
PSA = prostate-specific antigen; TBR = tumor-to-background ratio.